Based on the intracranial administration, early contact of EpCAM-directed CAR T-cell with EpCAM-transduced LL/2 tumor cells may lead to receptor–antigen interaction inducing activation, proliferation, and the development of a cytotoxic phenotype [50, 51]. This evidence concerns the gene EPCAM and neoplasm.